Ketorolac tromethamine - Novilla Pharmaceuticals
Alternative Names: ketorolac tromethamine gel - Novilla Pharmaceuticals; NOV-1776Latest Information Update: 11 Mar 2024
At a glance
- Originator Novilla pharmaceuticals
- Class 2 ring heterocyclic compounds; Carboxylic acids; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Pyrroles; Small molecules
- Mechanism of Action Cyclo-oxygenase 1 inhibitors; Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Acute pain
Most Recent Events
- 23 Feb 2024 Preclinical trials in Acute pain in USA (Topical) before February 2024
- 23 Feb 2024 Novilla Pharmaceuticals plans phase-I trial for Acute pain (In adults, in the elderly) in Australia (Topical, Gel) (NCT06273813),